Nps Pharmaceuticals Inc Watch

EX-4.2

from S-3ASR 71 pages Nps Pharmaceuticals, Inc. and the Bank of New York Mellon, as Trustee Indenture Dated as of August 8, 2013 Nps Pharmaceuticals, Inc. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of August 8, 2013

12/34/56

EX-4.3

from S-3 47 pages Nps Pharmaceuticals, Inc., as Issuer to [ ], as Trustee Form of Subordinated Indenture Dated as of , 201

12/34/56

EX-4.2

from S-3 43 pages Nps Pharmaceuticals, Inc. as Issuer to [ ], as Trustee Form of Senior Indenture Dated as of , 201

12/34/56

EX-4.3

from S-3 51 pages Nps Pharmaceuticals, Inc., as Issuer to [ ], as Trustee Form of Subordinated Indenture Dated as of , 200

12/34/56

EX-4.2

from S-3 47 pages Nps Pharmaceuticals, Inc. as Issuer to [ ], as Trustee Form of Senior Indenture Dated as of , 200

12/34/56

EX-4.3

from S-3 51 pages Nps Pharmaceuticals, Inc., as Issuer to [ ], as Trustee Form of Subordinated Indenture Dated as of , 200

12/34/56

EX-4.2

from S-3 47 pages Nps Pharmaceuticals, Inc. as Issuer to [ ], as Trustee Form of Senior Indenture Dated as of , 200

12/34/56

EX-4.7

from 8-K 20 pages Registration Rights Agreement

12/34/56

EX-4.6

from 8-K 25 pages Nps Pharmaceuticals, Inc. 5.75% Convertible Note Due 2014

12/34/56

EX-4.5

from 8-K 24 pages Securities Purchase Agreement

12/34/56

EX-4.4

from 8-K 36 pages Fifth Supplemental Indenture Dated as of August 7, 2007 by and Between Cinacalcet Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes, and U.S. Bank National Association, as Initial Trustee of the Notes

12/34/56

EX-4.3

from 8-K 13 pages Fourth Supplemental Indenture Dated as of August 1, 2007 by and Between Cinacalcet Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes, and U.S. Bank National Association, as Initial Trustee of the Notes

12/34/56

EX-4.2

from 8-K 4 pages Third Supplemental Indenture Dated as of July 9, 2007 by and Between Cinacalcet Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes, and U.S. Bank National Association. as Initial Trustee of the Notes (Third Supplemental Indenture to the Indenture, Dated as of December 22, 2004, Between Cinacalcet Royalty Sub LLC and U.S. Bank National Association, as Previously Amended by the Supplemental Indenture, Dated as of February 5, 2005 and Second Supplemental Indenture, Dated as of October 20, 2006) Third Supplemental Indenture

12/34/56

EX-4.1

from 8-K 6 pages Second Supplemental Indenture Dated as of October 20, 2006 by and Between Cinacalcet Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes, and U.S. Bank National Association, as Initial Trustee of the Notes (Second Supplemental Indenture to the Indenture, Dated as of December 22, 2004, Between Cinacalcet Royalty Sub LLC and U.S. Bank National Association, as Previously Amended by the Supplemental Indenture, Dated as of February 5, 2005) Second Supplemental Indenture

12/34/56

EX-4.3

from S-3ASR ~50 pages Nps Pharmaceuticals, Inc., as Issuer to U. S. Bank National Association, as Trustee Form of Subordinated Indenture Dated as of , 200

12/34/56

EX-4.2

from S-3ASR ~50 pages Nps Pharmaceuticals, Inc., as Issuer to U. S. Bank National Association, as Trustee Form of Senior Indenture Dated as of , 200

12/34/56

EX-4.3

from S-3 ~50 pages Nps Pharmaceuticals, Inc., as Issuer to U. S. Bank National Association, as Trustee Form of Subordinated Indenture Dated as of , 200

12/34/56

EX-4.2

from S-3 ~50 pages Nps Pharmaceuticals, Inc., as Issuer to U. S. Bank National Association, as Trustee Form of Senior Indenture Dated as of , 200

12/34/56

EX-4.1

from 8-K 84 pages Indenture Dated as of December 22, 2004 by and Between Cinacalcet Royalty Sub LLC, a Delaware Limited Liability Company, as Issuer of the Notes, and U.S. Bank National Association. as Initial Trustee of the Notes

12/34/56

EX-4.4

from S-3 ~20 pages Nps Pharmaceuticals, Inc. Registration Rights Agreement

12/34/56